Arash Salardini, MD, is a co-director of the Yale Memory Clinic and one of the few behavioral neurologist/neuropsychiatrists in Connecticut. He cares for patients with such conditions as Alzheimer’s disease, vascular dementia and traumatic brain injury that can change cognition. “When it comes to dementia, most people have heard about the worst case scenarios,” he says. “But many patients can learn techniques and plan in a way that maximizes their independence for a long time to come.”
Dr. Salardini and his colleagues provide innovative therapies that can help control symptoms, and often delay or eliminate institutionalization. He is gratified when he is able to tailor treatment plans for patients who are struggling with cognitive difficulties even after visits with numerous physicians.
An associate leader of the clinical core at the Yale Alzheimer’s Disease Research Center, Dr. Salardini is working on an algorithm to predict the risk of developing dementia in patients with mild cognitive impairment and studying the role of inflammation in Alzheimer’s. “We are only years away from being able to stop the progression of early Alzheimer's disease, and one day soon we may be able to screen at-risk populations and treat them before the disease progresses significantly,” he says.